SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending due to its highly provocative name, sparking widespread disbelief and drawing comparisons to other humorously named meme coins in the community. Investors are actively discussing its perceived absurdity, with some humorously embracing its speculative nature while others decry it as a prime example of the market's increasing embrace of joke assets and potential scams.

Alchemy Pay

Alchemy Pay (ACH) is seeing increased attention following its integration with Ripple's RLUSD stablecoin, significantly expanding its global fiat on-ramp capabilities. Further fueling community discussion are reports of Alchemy Pay securing its tenth U.S. Money-Transmitter License and a whitepaper outlining its shift towards a stablecoin-focused Layer1 blockchain, driving optimism for its compliant, enterprise-grade payment solutions and potential for future growth.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Journey Medical Corp. is trending following the FDA approval and anticipated commercial launch of its rosacea drug, Emrosi (DFD-29), a development significantly bolstered by a recent black box warning for competitor Oracea. Investors are highly optimistic about Emrosi's potential as a best-in-class, standard-of-care treatment, with many seeing the stock as deeply undervalued given its revenue and profitability prospects. The community is now focused on an upcoming commercialization call for key details regarding market launch and financial outlook, which is expected to clarify its path to significant growth.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

Vor Biopharma is trending following major analyst endorsements, including an "Overweight" rating and a substantial price target from JPMorgan, coupled with a "Buy" rating from TD Cowen. The community is actively debating the significant upside potential, fueled by its lead autoimmune drug's recent Phase 3 clinical success and strategic financing, while also acknowledging its characteristic volatility.

Wishing Well

WISH CRYPTO is gaining significant attention from its community, fueled by an active weekend contest, continuous vision updates on X, and anticipation for its chart to go fully live on major platforms. Investors are discussing its unique deflationary tokenomics, which includes monthly burns tied to US inflation, and its strong community backing as a long-term HODL opportunity that stands apart from typical memecoins.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund (UUP) is trending as market participants keenly debate the Federal Reserve's monetary policy path, widely anticipating rate cuts that could pressure the dollar. Despite this, a notable segment of the community is actively buying UUP calls, anticipating a potential flight to safety amidst global market uncertainties and diverging central bank actions.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DRB CRYPTO (DebtReliefBot) is gaining significant attention within the crypto community, driven by its unique identity as an AI-to-AI generated token with strong perceived ties to Grok. Enthusiasts are highlighting its current low market capitalization, suggesting it holds considerable growth potential as a "sleeper" asset in the expanding AI and Base/Farcaster ecosystem.

Braze, Inc. operates a customer relationship management platform for mobile applications. Its application combines messaging, audience segmentation, analytics and user support in a single integrated solution. The firm offers push notifications, email, in-app messages, and news feed services. The company was founded by Mark Ghermezian, William Magnuson, and Jonathan Hyman in 2011 and is headquartered in New York, NY.

Braze Inc - Ordinary Shares - Class A

Braze Inc

Braze is trending due to a robust earnings report that exceeded expectations and included raised full-year guidance, which spurred a wave of analyst upgrades and increased price targets. While many in the community are bullish on its customer engagement platform, citing strong growth, AI integration, and a recent acquisition as catalysts for a potential breakout or buyout, others remain highly skeptical about its long-term profitability and competitive landscape.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending due to heightened speculation surrounding an imminent buyout, particularly from Nestl, fueled by its limited cash runway and recent scientific publications validating its microbiome platform. While long-term investors express deep frustration over management's perceived lack of transparency, the community remains actively engaged in discussions about a potential acquisition or significant partnership.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending as intensifying geopolitical developments in the Middle East dominate investor conversation, with particular focus on potential impacts to global oil supply and shipping routes. The community is keenly observing how these events, alongside anticipated shifts in energy policy, could influence this leveraged oil and gas exploration and production ETF. Many anticipate significant price action, reflecting its inherent volatility and sensitivity to market catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fjarde AP Fonden Fourth Swedish National Pension Fund Buys 1,800 Shares of MSCI Inc $MSCI

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in MSCI Inc (NYSE:MSCI - Free Report) by 14.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

MSCI Inc $MSCI Stock Holdings Raised by Ycg LLC

Ycg LLC increased its position in MSCI Inc (NYSE:MSCI - Free Report) by 4.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned...

If You Invested $1000 In Fidelity MSCI Information Technology Index ETF Stock 5 Years Ago, You Would Have This Much Today

MSCI Inc $MSCI Shares Sold by EULAV Asset Management

EULAV Asset Management reduced its stake in shares of MSCI Inc (NYSE:MSCI - Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...

Futures Jump As Blowout TSMC Earnings Reboot Tech Trade

Futures Jump As Blowout TSMC Earnings Reboot Tech Trade US equity futures are higher led by Tech stocks which bounced back on Thursday after chipmaker TSMC revived confidence in the durability of...

Manning & Napier Advisors LLC Reduces Stock Holdings in MSCI Inc $MSCI

Manning & Napier Advisors LLC reduced its holdings in shares of MSCI Inc (NYSE:MSCI - Free Report) by 75.7% during the 3rd quarter, according to its most recent filing with the Securities and...

MSCI Inc (NYSE:MSCI) Given Consensus Rating of "Moderate Buy" by Brokerages

MSCI Inc (NYSE:MSCI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven analysts that are presently covering the firm, MarketBeat Ratings reports. Four equities...

MSCI (NYSE:MSCI) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Wells Fargo & Company boosted their target price on shares of MSCI from $570.00 to $590.00 and gave the company an "equal weight" rating in a research note on Wednesday...

<ul class="summary-bullets"><li>As of January 11, Strategy holds 687,410 Bitcoin, worth around $62 billion at current bitcoin price.</li><li>Earlier on Monday, Saylor had indicated a sizable bitcoin buy from Strategy.</li><li>On Friday, major U.S. bank Wells Fargo announced that it has bought $383 million worth of bitcoin ETFs.</li></ul><p>Shares of Michael Saylor-backed Strategy rallied on Monday after it disclosed it has bought bitcoin worth about $1.25 billion.&nbsp;</p><p>Strategy bought 13,627 bitcoins between January 5 and January 11, by using proceeds from the sale of shares of Variable Rate Series A Perpetual Stretch Preferred stock and Strategy’s stock under Strategy's at-the-market offering program (ATM), according to a regulatory filing filed with U.S. Securities and Exchange Commission.&nbsp;</p><p>As of January 11, Strategy held 687,410 BTC acquired for an aggregate purchase price of about $51.8 billion at an average purchase price of $75,353 per bitcoin. However, at current bitcoin price, the stash is worth about $62 billion. &nbsp;</p><p>Earlier on Monday, Saylor had indicated a sizable bitcoin buy from Strategy by writing “Big Orange” in his post on X. STR’s executive chairman has been using “orange” and “green” signals to indicate the company’s purchases over the past week, usually before the official announcement.&nbsp;</p><p>Last week, Strategy disclosed that it had acquired 1,286 bitcoins for about $116 million.&nbsp;</p><h2 class="st-heading-2">Rising Bitcoin ETF Popularity</h2><p>With easing regulation around digital currencies under President Donald Trump's administration, more and more firms are buying and investing in exchange traded funds (ETFs). On Friday, major U.S. bank Wells Fargo announced that it has bought $383 million worth of bitcoin ETFs.</p><p>Major institutions buying bitcoin through ETFs have supported bitcoin prices in recent times. Major firms like world’s largest asset manager BlackRock have their own bitcoin ETFs that it launched in 2024.&nbsp;</p><h2 class="st-heading-2">Boost From MSCI</h2><p>MSCI recently said that it will continue to allow digital asset treasury (DAT) firms to remain in its indexes. MSCI had earlier proposed to exclude crypto treasury firms from its global indexes, serving as a major boost for firms like Strategy which is one of the world’s largest DAT.&nbsp;</p><p>MSCI said that the current index treatment of DAT companies identified in the preliminary list published by MSCI of companies whose digital asset holdings represent 50% or more of their total assets will remain unchanged.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>Retail sentiment around MSTR trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;</p><p>Shares of Strategy have fallen nearly 48% over the past year.&nbsp;<br>&nbsp;</p>

In this photo illustration, a Strategy logo is seen displayed on a smartphone ans in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Michael Saylor’s Strategy Buys Bitcoin Worth About $1.25B – Shares Rally

Strategy bought 13,627 bitcoins between January 5 and January 11, by using proceeds from the sale of shares of STRC Stock and MSTR Stock. 

Equity

Strategy bought 13,627 bitcoins between January 5 and January 11, by using proceeds from the sale of shares of STRC Stock and MSTR Stock. 


Bullish Two Hundred Day Moving Average Cross - FSTA

In trading on Monday, shares of the Fidelity MSCI Consumer Staples Index ETF (Symbol: FSTA) crossed above their 200 day moving average of $50.59, changing hands as high as $50.74 per share. Fidelity...

MSCI, Inc. engages in the provision of investment decision support tools including indices, portfolio risk and performance analytics and corporate governance products and services. It operates through the following segments: Index, Analytics, ESG and Climate, and All Other-Private Assets. The Index segment focuses on the investment process, including developing indexed financial products. The Analytics segment offers risk management, performance attribution and portfolio management content, applications, and services. The ESG and Climate segment includes providing data, ratings, research, and tools to help investors navigate increasing regulation, meet new client demands and better integrate ESG and climate elements into their investment processes. The All Other-Private Assets segment refers to the business intelligence products to real estate owners, managers, developers, and brokers. The company was founded by Andrew Thomas Rudd in 1998 and is headquartered in New York, NY.

MSCI
MSCI Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MSCI News

MSCIMSCI Inc